References
- GRISWOLD DE, ADAMS JL: Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): ration-ale for selective inhibition and progress to date. Med. Res. Rev. (1997) 121:105–117.
- BRATTISTINI B, BOTTING R, BAKHLE YS: COX-1 and COX-2: toward the development of more selective NSAIDs. Drug News Pei-spirt. (1994) 7:501–512.
- RIENDEAU D, PERCIVAL MD, BOYCE S et al.: Biochemical and pharmacological profile of a tetrasubstituted fura-none as a highly selective COX-2 inhibitor. Br. J. Phar-macol (1997) 121:105–117.
- MASFERRER JL, ZVVEIFEL BS, MANNING PT et al.: Selective inhibition of inducible cyclooxygenase-2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. ScL USA (1994) 91:3228–3232.
- FUTAKI N, TAKAHASHI S, YODOYAMA M, ARAIL I, HI GUCHI S, OTOMO S: NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H syn-thase/cyclooxygenase (COX-2) activity in vitro. Pro-staglandins (1994) 47:55–59.
- DAVIS R, GROGDEN RN: Nimesulide, an update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs (1994) 48:431–454.
- WIESENBERG-BOTTCHER I, SCHWEIZER A, GREEN JR, SELTENMEYER Y, MULLER K: The pharmacological pro-file of CGP 28238, a highly potent anti-inflammatory compound. Agents Actions (1989) 26:240–242.
- LI CS, BLACK WC, CHAN CC et al.: Cyclooxygenase-2 inhibitors. Synthesis and pharmacological activities of 5-methanesuflonamido-1-indanone derivatives. j Med. Chem. (1995) 38:4897–4905.
- CHAN CC, BLACK C, BOYCE S eta].: Pharmacology of a selective cyclooxygenase-2 inhibitor L-745,337: a novel non-steroidal anti-inflammatory agent with an ulcero-genic sparing effect in rat and primate stomach. J. Pharmacol Exp. Ther. (1995) 274:1531–1537.
- TSUJI K, NAKAMURA K, KONISHI N, OKUMURA H, MAT-SUO M: Studies on antiinflammatory agents. I. Synthesis and pharmacological properties of 2'-phe-noxymethanesulfonanilide derivatives. Chem. Pharm. Bull. (1992) 40:2399–2409.
- TANAKA K, MAKINO S, SHIMOTORI T et al.: Pharma-cological studies of the new antiinflammatory agent 3-formylamino - 7 - methylsulfonylamino -6- phenoxy-411-1-benzopyran-4-one. Arzneim.-Forsch. Drug Res. (1992) 42:935–950.
- PROUS J, MEALY N, CASTANER J: T-614. Drugs Future (1993) 18:714–716.
- PRASIT P, BLACK WC, CHAN CC et al.: L-745,337: aselective cyclooxygenase-2 inhibitor. Med. Chem. Res. (1995) 5:364–374.